SCHEMBL20127623

SCHEMBL20127623

c1ccc2c(c1)oc1c(-c3ccc(-c4c5ccccc5c(-c5ccc6oc7c(ccc8c9ccccc9oc87)c6c5)c5ccccc45)cc3)cccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.56
PRKDC P78527 5/20 0.44
GGPS1 O95749 1/20 0.42
PTGES2 Q9H7Z7 1/20 0.39
MAPT P10636 3/20 0.38
NPC1 O15118 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
KMT2A Q03164 2/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
ATM Q13315 1/20 0.37
AHR P35869 3/20 0.36
PLA2G10 O15496 1/20 0.35
PLA2G2A P14555 1/20 0.35
PLA2G4A P47712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127633 0.93 ALOX5 (0.58) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL20127614 0.93 ALOX5 (0.54) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL22414230 0.92 ALOX5 (0.53) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL126817 0.92 ALOX5 (0.53) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL125667 0.91 ALOX5 (0.56) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL19770494 0.91 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL16067514 0.91 ALOX5 (0.50) ALOX5PRKDCGGPS1MAPTKDM4E
SCHEMBL23057014 0.91 ALOX5 (0.56) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL10122397 0.91 ALOX5 (0.46) ALOX5PRKDCGGPS1MAPTNPC1
SCHEMBL27341814 0.90 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885PRKDC 3891/4885GGPS1 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.